Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Expert Profile
Views:
116
Share
QR code
Edit Profile
Sarah Glover
Associate Professor
MD-GASTROENTEROLOGY | COLLEGE-MEDICINE
View:
Select
All (all in one)
Research Terms and Keywords
Publications
Co-Investigator Network
Websites
Contact
All
Research
Publications
Network
Websites
Contact
Research Terms & Keywords
Research Terms
Gastroenterology
Research Projects
Ends
Title
01-2022
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
12-2019
A Phase 3 Open label Study to Determine the Long Term Safety and Efficacy of MLN002 in Patients with Ulcerativ colitis and Crohn's Disesease Millenium C13008
A Phase 3 Open label Study to Determine the Long Term Safety and Efficacy of MLN002 in Patients with Ulcerativ colitis and Crohn's Disesease Millenium C13008
10-2019
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn#s Disease
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn#s Disease
10-2019
SECURE: A Non-Interventional Long-term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia?) for Crohn's Disease - Protocol: C87075
SECURE: A Non-Interventional Long-term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia?) for Crohn's Disease - Protocol: C87075
02-2019
IBD Research and Education - UFF Fund #008463
IBD Research and Education - UFF Fund #008463
06-2018
Defective STAT3 Signaling in Inflammatory Bowel Disease
Defective STAT3 Signaling in Inflammatory Bowel Disease
06-2018
A Single Arm Open-Label Study to Assess Mucosal Healing in Patients with Moderately to Severely Active Crohn's Disease Treated with Vedolizumab
A Single Arm Open-Label Study to Assess Mucosal Healing in Patients with Moderately to Severely Active Crohn's Disease Treated with Vedolizumab
04-2018
A Open-Label Extension Study of CP-690, 550 as Maintenance Therapy in Patients with Crohn's Disease'
A Open-Label Extension Study of CP-690, 550 as Maintenance Therapy in Patients with Crohn's Disease'
03-2018
A Randomized Double-Blind multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn's Disease
A Randomized Double-Blind multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn's Disease
02-2018
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLEDSTUDY OF ABT-494 FOR THE INDUCTION OF SYMPTOMATIC AND .....
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLEDSTUDY OF ABT-494 FOR THE INDUCTION OF SYMPTOMATIC AND .....
01-2018
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTRE STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CP-690,550 FOR INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE CROHN#S DISEASE
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTRE STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CP-690,550 FOR INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE CROHN#S DISEASE
01-2018
GA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTRE STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CP-690,550 FOR INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE CROHN#S DISEASE
GA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTRE STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CP-690,550 FOR INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE CROHN#S DISEASE
12-2017
EPIC Inflammatory Bowel Disease SmartForm
EPIC Inflammatory Bowel Disease SmartForm
10-2017
CD INFORM Investigating Natalizumab Through Further Observational Research and Monitoring
CD INFORM Investigating Natalizumab Through Further Observational Research and Monitoring
08-2017
A Phase 2, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects with Eosinophilic Esophagitis
A Phase 2, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects with Eosinophilic Esophagitis
07-2017
Phenotypical and quantitative analyses of leukocyte populations in matched blood and intestinal tissues in IBD patients and normal healthy patients
Phenotypical and quantitative analyses of leukocyte populations in matched blood and intestinal tissues in IBD patients and normal healthy patients
09-2016
A Phase 2a, randomized, double blind, placebo controlled, multi-center study to evaluate the safety and efficacy of intravenous infusion of Human Placenta-Derived Cells (PDA001) for the treatment of adults with moderate-to-severe Crohn#s disease.
A Phase 2a, randomized, double blind, placebo controlled, multi-center study to evaluate the safety and efficacy of intravenous infusion of Human Placenta-Derived Cells (PDA001) for the treatment of adults with moderate-to-severe Crohn#s disease.
06-2016
Prospective Cohort of Ulcerative Colitis and Crohn#s Disease Patients Undergoing Surgery to Identify Risk Factors for Post-Operative Infection I
Prospective Cohort of Ulcerative Colitis and Crohn#s Disease Patients Undergoing Surgery to Identify Risk Factors for Post-Operative Infection I
05-2016
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-00547659 IN SUBJECTS WITH CROHN#S DISEASE (OPERA)
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-00547659 IN SUBJECTS WITH CROHN#S DISEASE (OPERA)
11-2015
A Randomized, Double-Blind, Placebo-Controlled Dose-Esclation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled Dose-Esclation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease
11-2015
BMS IM133-005
BMS IM133-005
10-2015
Janssen UNITI 2
Janssen UNITI 2
07-2015
C0524T18 A Phase 3 Multi-center, Randomized, Placebo-con
C0524T18 A Phase 3 Multi-center, Randomized, Placebo-con
05-2015
A Phase 3, Randomized, Placebo-Controlled, Blinded...
A Phase 3, Randomized, Placebo-Controlled, Blinded...
05-2015
A Phase 3, Randomizedd, Placebo Controlled, Blinded Mult
A Phase 3, Randomizedd, Placebo Controlled, Blinded Mult
07-2014
The Role of Surface Roughness in Regulating Cell Behavio
The Role of Surface Roughness in Regulating Cell Behavio
07-2014
M10-223 A Multicenter, Open-Label Study of the Tolerabil
M10-223 A Multicenter, Open-Label Study of the Tolerabil
04-2014
BMS IM129-005
BMS IM129-005
01-2014
Millennium C13011
Millennium C13011
12-2013
The Role of Smoking in Promotion of Crohn’s disease, a P
The Role of Smoking in Promotion of Crohn’s disease, a P
02-2013
Genentech_GA29727
Genentech_GA29727
02-2013
Prometheus - 10IBD02
Prometheus - 10IBD02
12-2012
CCFA Pregnancy Study Continuation
CCFA Pregnancy Study Continuation
09-2012
Genentech ABS4986g
Genentech ABS4986g
Publications
Search Google Scholar for Sarah Glover
Co-Investigator Network
Nicole Iovine
Program Director; Clinical Professor & Hospital Epidemiologist
University of Florida
MD-INFECTIOUS DISEASES, College-Medicine
nicole.iovine@medicine.ufl.edu
Marcus Muehlbauer
Program Director & Assistant Professor
University of Florida
MD-GASTROENTEROLOGY, College-Medicine
marcus.muehlbauer@medicine.ufl.edu
Inactive Expert
John Valentine
ASO PROFESSOR
University of Florida
MD-GASTROENTEROLOGY, College-Medicine
valenjf@medicine.ufl.edu
Websites
Search Google Scholar for Sarah Glover
Contact Information
sarah.glover@medicine.ufl.edu
6019844543
2500 N STATE ST JACKSON, MS 39216-4500
Profile QR code
What is this?
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation
